Targeting high-risk young patients for statin therapy Editorial Article uri icon

Overview

MeSH Major

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hyperlipoproteinemia Type II

publication date

  • July 21, 2004

Research

keywords

  • Editorial

Identity

Digital Object Identifier (DOI)

  • 10.1001/jama.292.3.377

PubMed ID

  • 15265854

Additional Document Info

start page

  • 377

end page

  • 8

volume

  • 292

number

  • 3